Item 6. Exhibits
6K characters. Original on sec.gov ·
Item 6. Exhibits
| Number | Description | |||||||
| 10.1*+ | Amendment No. 9, dated as of August 25, 2026, to the Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care Inc. dated as of September 13, 2021. | |||||||
| 10.2# | Insulet Nonqualified Deferred Compensation Plan (Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K, filed September 16, 2026). | |||||||
| 10.3 | Ninth Amendment to Credit Agreement, dated September 21, 2026, among Insulet Corporation, Insulet MA Securities Corporation, Morgan Stanley Senior Funding, Inc., as administrative agent, and the other lenders party thereto (Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K, filed September 21, 2026). | |||||||
| 31.1* | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Chief Executive Officer. | |||||||
| 31.2* | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Chief Financial Officer. | |||||||
| 32.1** | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, by Chief Executive Officer and Chief Financial Officer. | |||||||
| 101 | The following materials from Insulet Corporation’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 formatted in iXBRL (Inline eXtensible Business Reporting Language), as follows: | |||||||
| (i) Condensed Consolidated Balance Sheets (Unaudited) as of September 30, 2026 and December 31, 2025 | ||||||||
| (ii) Condensed Consolidated Statements of Income (Unaudited) for the three and nine months ended September 30, 2026 and 2025 | ||||||||
| (iii) Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three and nine months ended September 30, 2026 and 2025 | ||||||||
| (iv) Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) for the three and nine months ended September 30, 2026 and 2025 | ||||||||
| (v) Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2026 and 2025 | ||||||||
| (vi) Condensed Notes (Unaudited) to Consolidated Financial Statements | ||||||||
| * | Filed herewith. | |||||||
| ** | Furnished herewith. | |||||||
| + | Certain portions of this exhibit are considered confidential and have been omitted as permitted under SEC rules and regulations. | |||||||
| # | Management contract or compensation plan. | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| INSULET CORPORATION (Registrant) | ||||||||
| Date: | November 4, 2026 | /s/ Ashley A. McEvoy | ||||||
| Ashley A. McEvoy | ||||||||
| Chief Executive Officer (Principal Executive Officer) |
| Date: | November 4, 2026 | /s/ Flavia H. Pease | ||||||
| Flavia H. Pease | ||||||||
| Chief Financial Officer, Executive Vice President (Principal Financial Officer) |